0xmd Partners with SENAI CIMATEC to Launch Operations in Brazil
|
HONG KONG SAR - Media OutReach Newswire - 12 May 2025 - 0xmd, a global startup specializing in Generative Artificial Intelligence for healthcare, has entered into a strategic partnership with SENAI CIMATEC, one of Brazil's leading technology and innovation institutions. This agreement marks the beginning of 0xmd's operations in Brazil, expanding the company's presence in the Latin American market. The issuer is solely responsible for the content of this announcement. About 0xmd0xmd Inc. is a pioneer in Generative AI healthcare solutions platform based in Hong Kong China and the US, specializing in Large Language Models (LLMs) and Large Visual Language Models (LvLMs) designed for medical applications. 0xmd is capable of providing 24/7 online diagnostic support that integrates both Western Medicine and Traditional Chinese Medicine, automation of clinical exam analysis, medical image diagnostics, as well as total health management solutions. The company is dedicated to transforming the healthcare landscape by optimizing healthcare systems, in order to make healthcare resources more equitable and accessible. About SENAI CIMATECSENAI CIMATEC is Brazil's leading technology and innovation center, comprising a Technological Center, a University, and a Technical School that operate in synergy. Established in 2002, it is a private, non-profit institution dedicated to Research, Development, and Innovation (RD&I), focusing on delivering advanced solutions to the industry. With expertise in 43 areas—including robotics, quantum computing, AI, energy, and sustainability—SENAI CIMATEC is committed to driving technological advancements to meet the evolving market needs. The institution develops and implements projects with national and international impact, collaborating with renowned institutions and partners worldwide.  News Source: 0xmd
12/05/2025 Dissemination of a Financial Press Release, transmitted by EQS News. |
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.